ArticleThe New England journal of medicine2023
Response to: Multiple Cerebral Hemorrhages in a Patient Receiving Lecanemab and Treated with t-PA for Stroke.
Article in The New England journal of medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 20 citations in OpenAlex.
- Implications of the Approval of Lecanemab for Alzheimer Disease Patient Care: Incremental Step or Paradigm Shift?Neurology · 2023Trial
- New Frontier, New Challenges-Recognizing and Managing Adverse Effects of Antiamyloid Therapies.JAMA internal medicine · 2025Article
- [Pharmacological developments in Alzheimer's disease].Atencion primaria · 2025Article
- Challenges for emergency departments: Anti-amyloid therapy and amyloid-related imaging abnormalities in persons with dementia.Journal of the American Geriatrics Society · 2024Article
- Lecanemab.Hospital pharmacy · 2024Review
- Pin1-catalyzed conformational regulation after phosphorylation: A distinct checkpoint in cell signaling and drug discovery.Science signaling · 2024Review
- Apolipoprotein E Genetic Testing in a New Age of Alzheimer Disease Clinical Practice.Neurology. Clinical practice · 2024Article
- The Impact of Anti-Amyloid Immunotherapies on Stroke Care.Journal of clinical medicine · 2024Review
- From network pharmacology to molecular docking analysis of sterubin targets for Alzheimer.Bioinformation · 2024Article
- Antiamyloid Monoclonal Antibody Therapy for Alzheimer Disease: Emerging Issues in Neurology.Neurology · 2023Review
- An anti-amyloid therapy works for Alzheimer's disease: why has it taken so long and what is next?Brain : a journal of neurology · 2023Article
Corrections and comments
- Comment on
- Comment on
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.